Litigation Details for Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
| Docket | 1:16-cv-00377 | Date Filed | 2016-05-20 |
| Court | District Court, D. Delaware | Date Terminated | 2016-06-16 |
| Cause | 28:1331 Fed. Question | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 8,637,512; 9,144,547 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC
Details for Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-05-20 | External link to document | |||
| 2016-05-20 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,637,512; 9,144,547;(aah) (Entered…2016 16 June 2016 1:16-cv-00377 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
